Careers

Agios is a biopharmaceutical company passionately committed to applying our scientific leadership in the field of cellular metabolism to transform the lives of patients with cancer and rare gentic disorders of metabolism.
NASDAQ: AGIO$84.37 Stock is Up 5.01 (6.31%)

UPCOMING EVENTS

Read more
Friday, November 7, 2014 8:00 a.m. ET
Agios Pharmaceuticals Third Quarter 2014 Financial Results Conference Call

CONTACTS

Investor Inquiries:
General inquiries: investors@agios.com

Institutional Investors and Financial Analysts:
Lora Pike
617-649-8608
Lora.pike@agios.com

Media Inquiries:
Dan Budwick
Pure Communications
973-271-6085